TrialFind
Saved trials
Back to results
Completed
Phase 2
GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease
NCT00414622
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Clinical Dept.
280 South San Francisco, California, United States
View on ClinicalTrials.gov
Official details
GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease — TrialFind